IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
16 hedge funds and large institutions have $221K invested in ImmunoCellular Therapeutics, Ltd. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WS
1
Wedbush Securities
Los Angeles,
California
|
$32K |
| 2 |
2
Renaissance Technologies
New York
|
$112K |
| 3 |
VKH
3
Virtu KCG Holdings
New York
|
$12K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$55K |
